NRXP - NRx Pharmaceuticals Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Global Market Current Price & Safety Score Price: 2.69 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -13.63 StockBond Score: -2.82 Company Description NRx Pharmaceuticals Inc is a clinicalstage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases Its product portfolio features ZYESAMI an experimental medication that has successfully completed Phase IIbIII clinical trials for treating respiratory failure associated with COVID19 Additionally the company is advancing NRX100 and NRX101 a pair of oral therapeutics designed to address bipolar depression specifically in patients exhibiting acute or subacute suicidal thoughts and behaviors Established in 2015 NRx Pharmaceuticals is headquartered in Wilmington Delaware